9.23
price down icon0.65%   -0.06
after-market Dopo l'orario di chiusura: 9.09 -0.14 -1.52%
loading
Precedente Chiudi:
$9.29
Aprire:
$9.25
Volume 24 ore:
820.61K
Relative Volume:
1.49
Capitalizzazione di mercato:
$977.55M
Reddito:
-
Utile/perdita netta:
$-174.61M
Rapporto P/E:
-4.3744
EPS:
-2.11
Flusso di cassa netto:
$-165.54M
1 W Prestazione:
+12.84%
1M Prestazione:
+28.37%
6M Prestazione:
+0.11%
1 anno Prestazione:
+9.75%
Intervallo 1D:
Value
$8.98
$9.49
Intervallo di 1 settimana:
Value
$7.67
$9.52
Portata 52W:
Value
$6.8802
$16.63

89 Bio Inc Stock (ETNB) Company Profile

Name
Nome
89 Bio Inc
Name
Telefono
(415) 432-9270
Name
Indirizzo
142 SANSOME STREET, SAN FRANCISCO, CA
Name
Dipendente
70
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
ETNB's Discussions on Twitter

89 Bio Inc Stock (ETNB) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-05-12 Aggiornamento Raymond James Outperform → Strong Buy
2021-12-20 Iniziato H.C. Wainwright Buy
2021-10-26 Ripresa Cantor Fitzgerald Overweight
2021-07-29 Ripresa BTIG Research Buy
2021-05-25 Downgrade Raymond James Strong Buy → Outperform
2021-04-21 Iniziato Cantor Fitzgerald Overweight
2020-10-19 Iniziato Raymond James Strong Buy
2020-09-25 Aggiornamento BofA Securities Neutral → Buy
2020-07-31 Iniziato Piper Sandler Overweight
2020-07-23 Iniziato BTIG Research Buy
2020-07-07 Iniziato Chardan Capital Markets Buy
2019-12-09 Iniziato BofA/Merrill Neutral
2019-12-09 Iniziato Oppenheimer Outperform
2019-12-09 Iniziato RBC Capital Mkts Outperform
2019-12-09 Iniziato SVB Leerink Outperform
Mostra tutto

89 Bio Inc Borsa (ETNB) Ultime notizie

pulisher
04:24 AM

89bio to Participate in the UBS Global Healthcare Conference - The Manila Times

04:24 AM
pulisher
Nov 04, 2024

89bio (NASDAQ:ETNB) Shares Gap DownShould You Sell? - MarketBeat

Nov 04, 2024
pulisher
Nov 02, 2024

Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH - Yahoo Finance

Nov 02, 2024
pulisher
Nov 01, 2024

89bio's chief technical operations officer sells $226,994 in stock - Investing.com India

Nov 01, 2024
pulisher
Nov 01, 2024

89bio's chief technical operations officer sells $226,994 in stock By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

89bio (NASDAQ:ETNB) Trading 7.3% HigherStill a Buy? - MarketBeat

Nov 01, 2024
pulisher
Oct 29, 2024

89Bio: Surviving A Competitive SpaceFor Now (NASDAQ:ETNB) - Seeking Alpha

Oct 29, 2024
pulisher
Oct 28, 2024

Global Severe Hypertriglyceridemia (SHTG) Treatment Market Set to Reach USD 2675.37 Million by 2033 - PharmiWeb.com

Oct 28, 2024
pulisher
Oct 21, 2024

Canadian North Resources Inc. Reports Metal Extraction of 96-98% Nickel and Cobalt Using Low-carbon Footprint - EIN News

Oct 21, 2024
pulisher
Oct 21, 2024

Canadian North Resources Inc. Reports Metal Extraction of 96-98% Nickel and Cobalt Using Low-carbon Footprint Bio-Leaching Technology for the Ferguson Lake Project - The Manila Times

Oct 21, 2024
pulisher
Oct 21, 2024

Canadian North Resources Inc. Reports Metal Extraction of - GlobeNewswire

Oct 21, 2024
pulisher
Oct 19, 2024

Oak Valley Bancorp reports Q3 EPS 89c vs. 89c last year - Yahoo Finance

Oct 19, 2024
pulisher
Oct 18, 2024

Deckers Stock Rallies 89% in a Year: Lock in Gains or Stay Invested? - Yahoo Finance

Oct 18, 2024
pulisher
Oct 18, 2024

89bio, Inc. (NASDAQ:ETNB) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

Suvretta Capital Management's Strategic Reduction in 89bio Inc Holdings - Yahoo Finance

Oct 18, 2024
pulisher
Oct 17, 2024

89bio, Inc. (NASDAQ:ETNB) Short Interest Update - MarketBeat

Oct 17, 2024
pulisher
Oct 17, 2024

State Street Corp's Strategic Acquisition in 89bio Inc - Yahoo Finance

Oct 17, 2024
pulisher
Oct 15, 2024

89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024 - The Manila Times

Oct 15, 2024
pulisher
Oct 15, 2024

89bio Inc (ETNB) presents a great opportunity, but the stock is slightly overvalued - US Post News

Oct 15, 2024
pulisher
Oct 11, 2024

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Oct 11, 2024
pulisher
Oct 11, 2024

PCR Technologies Market to Hit USD 21.89 Billion by 2030 with 7.7% CAGR | MarketsandMarkets™ - PR Newswire

Oct 11, 2024
pulisher
Oct 10, 2024

Millennium Management LLC Sells 76,845 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Oct 10, 2024
pulisher
Oct 08, 2024

89bio (NASDAQ:ETNB) Trading Up 5.3%Here's Why - MarketBeat

Oct 08, 2024
pulisher
Oct 03, 2024

89bio Inc [ETNB] Chief Executive Officer makes an insider purchase of 52,718 shares worth 0.58 million. - Knox Daily

Oct 03, 2024
pulisher
Oct 03, 2024

Renaissance Technologies LLC Invests $2.24 Million in 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Oct 03, 2024
pulisher
Oct 02, 2024

Bank of Montreal Can Has $4.64 Million Stake in Repligen Co. (NASDAQ:RGEN) - Defense World

Oct 02, 2024
pulisher
Oct 01, 2024

89bio Inc (ETNB)’s stock price range in the last year - US Post News

Oct 01, 2024
pulisher
Sep 30, 2024

89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference - ForexTV.com

Sep 30, 2024
pulisher
Sep 30, 2024

The Potential Rise in the Price of 89bio Inc (ETNB) following insiders activity - Knox Daily

Sep 30, 2024
pulisher
Sep 30, 2024

What is 89bio Inc (ETNB) Stock Return on Shareholders’ Capital? - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Metric Deep Dive: Understanding 89bio Inc (ETNB) Through its Ratios - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Severe Hypertriglyceridemia Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | Ionis Pharma, 89bio, Inc., Arrowhead Pharma, Hightide Therapeutics, AstraZeneca, Kowa - Barchart

Sep 30, 2024
pulisher
Sep 30, 2024

Severe Hypertriglyceridemia Market Growth to Accelerate - openPR

Sep 30, 2024
pulisher
Sep 30, 2024

89Bio's SWOT analysis: pegoza's potential in competitive MASH market - Investing.com

Sep 30, 2024
pulisher
Sep 30, 2024

89Bio's SWOT analysis: pegoza's potential in competitive MASH market By Investing.com - Investing.com Australia

Sep 30, 2024
pulisher
Sep 26, 2024

Health Check: How Prudently Does 89bio (NASDAQ:ETNB) Use Debt? - Simply Wall St

Sep 26, 2024
pulisher
Sep 25, 2024

89bio Inc (ETNB) did well last session? - US Post News

Sep 25, 2024
pulisher
Sep 24, 2024

In the Green: 89bio Inc (ETNB) Closes at 7.67, Up/Down -6.35 from Previous Day - The Dwinnex

Sep 24, 2024
pulisher
Sep 23, 2024

89bio (NASDAQ:ETNB) Trading Down 2.9% - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

89bio, Inc. (NASDAQ:ETNB) Receives $30.14 Average PT from Brokerages - MarketBeat

Sep 23, 2024
pulisher
Sep 23, 2024

Adversity is less terrifying than hope: 89bio Inc (ETNB) - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Integral Health Asset Management LLC Buys 150,000 Shares of 89bio, Inc. (NASDAQ:ETNB) - MarketBeat

Sep 23, 2024
pulisher
Sep 20, 2024

89bio's (ETNB) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat

Sep 20, 2024
pulisher
Sep 20, 2024

Balakrishna pays tribute to ANR on his 100th Birth Anniversary - TrackTollywood

Sep 20, 2024
pulisher
Sep 20, 2024

2 Kite vets fly over to Kyverna Therapeutics—Chutes & Ladders - Fierce Biotech

Sep 20, 2024
pulisher
Sep 19, 2024

Saba capital management sells shares in Eaton Vance trust worth over $484k - Investing.com

Sep 19, 2024
pulisher
Sep 18, 2024

Brokerages Set East West Bancorp, Inc. (NASDAQ:EWBC) Price Target at $89.53 - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Ratio Examination: 89bio Inc (ETNB)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

Teresa Perney brought in to lead 89bio’s regulatory strategy - The Pharma Letter

Sep 17, 2024
pulisher
Sep 17, 2024

Bank of New York Mellon Corp Has $2.40 Million Stake in 89bio, Inc. (NASDAQ:ETNB) - Defense World

Sep 17, 2024
pulisher
Sep 17, 2024

Peter Maag resigns as Kyverna CEO - BioCentury

Sep 17, 2024

89 Bio Inc Azioni (ETNB) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):